HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christa Prins Selected Research

Lichen Planus (Lichen Ruber Planus)

11/2008Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christa Prins Research Topics

Disease

2Dermatomyositis (Dermatopolymyositis)
01/2012 - 01/2007
2Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2003 - 01/2003
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2014
1Common Variable Immunodeficiency
07/2013
1Necrobiosis Lipoidica
07/2013
1Thrombocytopenia (Thrombopenia)
04/2013
1Hypersensitivity (Allergy)
04/2013
1Melanoma (Melanoma, Malignant)
01/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2012
1Lichen Planus (Lichen Ruber Planus)
11/2008
1Erysipelas
10/2008
1Muir-Torre Syndrome
08/2006
1Polyradiculoneuropathy (Polyradiculoneuritis)
02/2006
1Anaphylaxis (Anaphylactic Shock)
02/2006
1Renal Insufficiency (Renal Failure)
02/2006
1Exanthema (Rash)
02/2006
1Disease Progression
02/2006
1Erythema
02/2005
1Hyperpigmentation
02/2005
1Leg Ulcer
02/2005
1Necrosis
02/2005
1Eczema
02/2005
1Cyanosis
02/2005
1Alopecia Areata
08/2002
1Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
05/2002

Drug/Important Bio-Agent (IBA)

5Intravenous Immunoglobulins (IVIG)FDA Link
07/2013 - 01/2003
2AntibodiesIBA
01/2012 - 05/2002
2Pharmaceutical PreparationsIBA
01/2003 - 05/2002
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2014
1Toll-Like Receptor 3IBA
05/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2014
1Heparin (Liquaemin)FDA LinkGeneric
04/2013
1Rituximab (Mabthera)FDA Link
01/2012
1Differentiation AntigensIBA
01/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2012
1Monoclonal AntibodiesIBA
11/2008
1Anti-Bacterial Agents (Antibiotics)IBA
10/2008
1Indicators and Reagents (Reagents)IBA
08/2006
1FibrinIBA
02/2005
1ImmunosorbentsIBA
05/2002
1EnzymesIBA
05/2002
1Immunoglobulin G (IgG)IBA
05/2002
1AntigensIBA
05/2002
1Collagen Type VIIIBA
05/2002

Therapy/Procedure

2Therapeutics
01/2007 - 01/2003
1Photopheresis
08/2002